{"id":4443,"date":"2025-03-23T16:02:31","date_gmt":"2025-03-23T16:02:31","guid":{"rendered":"https:\/\/csinterpharm.ae\/?p=2986"},"modified":"2026-02-05T13:36:41","modified_gmt":"2026-02-05T13:36:41","slug":"cs-diagnostics-corp-uplifts-from-otc-pink-to-otcqb-a-major-milestone-in-growth","status":"publish","type":"post","link":"https:\/\/csdcorp.us\/en\/cs-diagnostics-corp-uplifts-from-otc-pink-to-otcqb-a-major-milestone-in-growth\/","title":{"rendered":"CS Diagnostics Corp. Uplifts from OTC Pink to OTCQB \u2013 A Major Milestone in Growth"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"4443\" class=\"elementor elementor-4443\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e37a1bf e-flex e-con-boxed e-con e-parent\" data-id=\"e37a1bf\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-8983d21 e-con-full e-flex e-con e-child\" data-id=\"8983d21\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a64a80b elementor-widget elementor-widget-heading\" data-id=\"a64a80b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Reference Social Media Posts:<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-32d4863 e-con-full e-flex e-con e-child\" data-id=\"32d4863\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-32db934 elementor-mobile-align-justify elementor-widget-mobile__width-inherit elementor-widget elementor-widget-button\" data-id=\"32db934\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/www.instagram.com\/p\/DB1dqGLSqJB\/?next=%2F\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">See Instagram Post  here<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-504524a elementor-mobile-align-justify elementor-widget-mobile__width-inherit elementor-widget elementor-widget-button\" data-id=\"504524a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/x.com\/csinterpharm\/status\/1852390332312289626\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">See Twitter X Post  here<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6fb8797 elementor-widget elementor-widget-text-editor\" data-id=\"6fb8797\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>CS Diagnostics\u00a0Corp. proudly celebrates its successful\u00a0uplift from the OTC Pink Market to the OTCQB in OTC Markets. The uplift\u00a0marks\u00a0a substantial development in CS Diagnostics\u00a0Corp\u2019s growth\u00a0and expanded market opportunities.\u00a0Our\u00a0ticker symbol has officially changed from\u00a0$FZRO\u00a0with an all new ticker symbol $CSDX, reflecting the uplift.\u00a0This milestone underscores\u00a0a positive step in further achieving the coming goals\u00a0of\u00a0commitment, growth, and shareholder value.<\/p><p>OTC Markets is a\u00a0decentralized trading platform where securities not listed on major stock exchanges, like NASDAQ or NYSE\u00a0are traded. It is divided into tiers, each representing different levels of regulatory compliance, transparency, and reporting standards.\u00a0The OTC Pink Market is the most basic tier, often associated with companies that provide limited financial disclosure. The OTCQB, on the other hand, is a mid-tier market designed for early-stage and developing companies that meet higher financial and reporting standards\u00a0and OTCQX \u00a0is the highest tier.<\/p><p>The uplift\u00a0from OTC Pink to OTCQB represents\u00a0a major\u00a0achievement\u00a0for CS Diagnostics\u00a0Corp. The companies listed on the OTCQB have to meet more\u00a0stringent financial and reporting criteria,\u00a0require annual verification, and are responsible for compliance with transparency requirements.\u00a0CS Diagnostics Corp. has met these standards, demonstrating its commitment to maintaining high levels of transparency and corporate governance.<\/p><p>Being listed on the OTCQB in fact has several advantages. Firstly, it\u00a0would\u00a0enhance CS Diagnostics Corp\u2019s visibility and exposure to a broader base of investors\u00a0ranging from\u00a0potential shareholders\u00a0to\u00a0analysts and institutional investors. This improved visibility can attract more investment which may bring additional investments\u00a0for funding growth initiatives. Examples would include expanding operations, investing in R&amp;D, or buying new products. Secondly, the OTCQB listing would further enhance the CS Diagnostics Corp\u2019s credibility to\u00a0investors, brokers, and market makers. It clearly demonstrates the company\u2019s commitment to responsible corporate governance and compliance with regulatory standards.<\/p><p>CS Diagnostics Corp. moving up from OTC Pink to OTCQB is not only a milestone but also an indicator that the company is headed in the right direction. Fundamentally, it is the unconventional leadership team, remarkable product portfolio, and focused vision that differentiates our company\u00a0from others in this sector.\u00a0The team takes immense\u00a0pride in this accomplishment and looks forward to supporting the vision\u00a0as it sets out\u00a0on this exciting new chapter.\u00a0CS Diagnostics Corp. remains\u00a0committed to driving innovation, creating value, and making a meaningful impact on\u00a0patient lives\u00a0and healthcare providers worldwide.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Reference Social Media Posts: See Instagram Post here See Twitter X Post here CS Diagnostics\u00a0Corp. proudly celebrates its successful\u00a0uplift from the OTC Pink Market to the OTCQB in OTC Markets. The uplift\u00a0marks\u00a0a substantial development in CS Diagnostics\u00a0Corp\u2019s growth\u00a0and expanded market opportunities.\u00a0Our\u00a0ticker symbol has officially changed from\u00a0$FZRO\u00a0with an all new ticker symbol $CSDX, reflecting the uplift.\u00a0This [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4570,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"class_list":["post-4443","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stories-history"],"_links":{"self":[{"href":"https:\/\/csdcorp.us\/en\/wp-json\/wp\/v2\/posts\/4443","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/csdcorp.us\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csdcorp.us\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csdcorp.us\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/csdcorp.us\/en\/wp-json\/wp\/v2\/comments?post=4443"}],"version-history":[{"count":7,"href":"https:\/\/csdcorp.us\/en\/wp-json\/wp\/v2\/posts\/4443\/revisions"}],"predecessor-version":[{"id":4569,"href":"https:\/\/csdcorp.us\/en\/wp-json\/wp\/v2\/posts\/4443\/revisions\/4569"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/csdcorp.us\/en\/wp-json\/wp\/v2\/media\/4570"}],"wp:attachment":[{"href":"https:\/\/csdcorp.us\/en\/wp-json\/wp\/v2\/media?parent=4443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csdcorp.us\/en\/wp-json\/wp\/v2\/categories?post=4443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csdcorp.us\/en\/wp-json\/wp\/v2\/tags?post=4443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}